Umbilical Cord Blood CD19-BCMA CART Cell Therapy

· Beijing GoBroad Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Umbilical Cord Blood CD19-BCMA CART Cell Therapy, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. [Phase 1, Phase 2]